Company Filing History:
2 out of 212 
2 out of 4,770 
Years Active: 1988-1990
Title: The Innovations of Edward C. Hayes
Introduction
Edward C. Hayes is a notable inventor based in Lincroft, New Jersey. He holds two patents that contribute significantly to the field of immunology and therapeutic agents. His work focuses on leukotrienes and their conjugates, which have potential applications in treating various allergic and chronic inflammatory diseases.
Latest Patents
Hayes' latest patents include innovative methods for conjugating leukotrienes with proteins such as Bovine Serum Albumin (BSA) and Hemocyanin from Giant Keyhole Limpets (KLH). These conjugates utilize coupling agents like 1,5-difluoro-2,4-dinitrobenzene or 6-N-maleimidohexanoic acid chloride. The resulting conjugates serve as valuable reagents in newly developed immunoassays for leukotrienes. Furthermore, they hold promise as chemical immunotherapeutic agents for treating conditions such as asthma, allergic rhinitis, rheumatoid arthritis, and skin diseases like psoriasis and eczema.
Career Highlights
Throughout his career, Edward C. Hayes has worked with prominent companies, including Merck Frosst Canada, Inc. and Merck & Company, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Hayes has collaborated with notable coworkers, including Robert N. Young and Joshua Rokach. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Edward C. Hayes is a distinguished inventor whose work on leukotriene conjugates has the potential to impact the treatment of various allergic and chronic inflammatory diseases. His contributions to the field of immunology are noteworthy and continue to inspire further research and innovation.